Skip to main content

Displaying 21 - 40 of 1540

Legion Media LLC, et al., FTC v.

In July 2024, a U.S. district court in central Florida unsealed a Federal Trade Commission complaint charging two related groups of defendants with defrauding consumers nationwide by enrolling them, without their knowledge, into continuity plans where they are shipped and charged repeatedly for personal care products that they did not agree to purchase.

The defendants allegedly deceived consumers with ads for “free” CBD and Keto-related personal care products, billing many for products they did not consent to purchase, signing many up for unwanted continuity plans, and debiting money from their bank accounts without prior authorization. In September 2024, the FTC announced three orders settling the Commission’s complaint and requiring the defendants to pay approximately $40 million in total to defrauded consumers. 

Type of Action
Federal
Last Updated
FTC Matter/File Number
242 3034
Case Status
Pending

Cerebral, Inc. and Kyle Robertson, U.S. v.

Cerebral, Inc. has agreed to an order that, will restrict how the company can use or disclose sensitive consumer data and require it to provide consumers with a simple way to cancel services to settle FTC charges that the telehealth firm failed to secure and protect sensitive health data.

Type of Action
Federal
Last Updated
FTC Matter/File Number
222 3067
Case Status
Pending

FTC Releases Fiscal Year 2023 Annual Report

Date
Following Public Service Recognition Week, the Federal Trade Commission released its Fiscal Year 2023 Annual Report outlining the agency’s work to protect consumers and promote competition. “The FTC...

Simple Health Plans LLC

On Oct. 29, 2018, the Federal Trade Commission filed a complaint in federal court against Simple Health Plans LLC, Steven J. Dorfman, and five other entities, alleging that the defendants misled people to think they were buying comprehensive health insurance that would cover preexisting medical conditions, prescription drugs, primary and specialty care treatment, inpatient and emergency hospital care, surgical procedures, and medical and laboratory testing. On Nov. 1, 2019, the FTC filed an amended complaint adding Candida Girouard as an additional defendant.  

Type of Action
Federal
Last Updated
FTC Matter/File Number
172 3148

Benefytt Technologies, et al., FTC v.

The Federal Trade Commission is taking action against healthcare company Benefytt Technologies, two subsidiaries, former CEO Gavin Southwell, and former vice president of sales Amy Brady, for lying to consumers about their sham health insurance plans and using deceptive lead generation websites to lure them in. According to the FTC complaint, Benefytt also illegally charged people exorbitant junk fees for unwanted add-on products without their permission. The proposed court orders require Benefytt to pay $100 million in refunds and prohibit the company from lying about their products or charging illegal junk fees. Southwell and Brady will be permanently banned from selling or marketing any healthcare-related product, and Brady will also be banned from telemarketing.

Type of Action
Federal
Last Updated
FTC Matter/File Number
192 3141
Case Status
Pending

The Bountiful Company

In February 2023, the FTC took action against a marketer of vitamins and other supplements called The Bountiful Company for abusing a feature of Amazon.com to deceive consumers into thinking that its newly introduced supplements had more product ratings and reviews, higher average ratings, and “#1 Best Seller” and “Amazon’s Choice” badges. The case against Bountiful marks the FTC’s first law enforcement challenging “review hijacking,” in which a marketer steals or repurposes reviews of another product. The company agreed to pay $600,000 in consumer redress to settle the FTC’s complaint. In March 2024, the Commission announced it was sending more than $527,000 to impacted consumers.

Type of Action
Federal
Last Updated
FTC Matter/File Number
2223019
Case Status
Pending